Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Primary Industries
- Medical
- Device
- Surgical
- Therapeutic
- implants
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 7008
License Grant
Licensor, a non-profit health care organization, hereby grants to Licensee the worldwide, sole exclusive License, including the right to grant subLicenses, under the Patent Rights and to practice the Licensed Processes.
License Property
This application generally relates to medical devices and more specifically relates to medical devices for use in the surgical treatment of hyperproliferative diseases affecting the spinal cord.
Field of Use
Field of Use shall mean treatment of Spinal cord injury.
IPSCIO Record ID: 4196
License Grant
The Licensee entered into an exclusive, subLicenseable, royalty bearing License with the Licensor, a University foundation, for the development and commercialization of the Licensor's technology.
License Property
This technology pertains to the Licensee's Oscillating Field Stimulator Device and the Oscillating Field Stimulator Device Plus, and a series of neurotrophic and other drugs to be utilized with the Oscillating Field Stimulator Device or on their own.
The existing platform includes a patented medical device known as an AndaraTM Oscillating Field Stimulator. The Device is being developed to regenerate spinal cord tissue and improve or restore tactile sensation and movement in those with quadriplegia and tetraplegia due to spinal cord injury.
Field of Use
The Device is designed to treat acute injuries and Devise Plus, which includes the use of neurotrophic growth factor, is being developed for long-term (chronic) spinal cord injuries.
IPSCIO Record ID: 4411
License Grant
The assignment of the intellectual property agreement for International Patent Application No. PCT/IB2010/000797 to Licensee, the Hong Kong affiliate.
License Property
PCT/IB2010/000797 A Device and Method for Lifting Abdominal Wall During Medical Procedure
IPSCIO Record ID: 2170
License Grant
The Company signed a Patent License, Research & Development Agreement in which the Company licensed the world-wide manufacturing and distribution rights to the spinal dissector.
License Property
The Spinal Dissector is patented minimally invasive devices for use in spinal surgery, which have been evaluated in vivo.
IPSCIO Record ID: 114966
License Grant
A group of prominent spine surgeons agree to assist in the development of the Synergy Spinal System for royalty payments of any sales generated.
License Property
Synergy Spinal System is in the spinal implant product category and is used in spine fusion procedures. The Synergy Spinal System consists of rods, hooks and screws that are attached to vertebrae adjacent to an injured or defective area of the spine. Our system is a 'universal' implant system that allows surgeonsto treat both the thoracic and lumbar portions of the spine. The Synergy Spinal System does not require that surgeons follow a single surgical protocol, but provides several options, and can be used in both anterior and posterior applications, in both adults and children. The Synergy Spinal System was designed to minimize the height and bulk of its implants, reducing the risk of irritation, inflammation and infection for the patient. It is consistently ranked as having one of the lowest profiles of commonly available spinal implant systems.
Field of Use
This agreement pertains to the medical device industry–spinal implants and orthobiologics.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
